Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter’s Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Source
5.1.1 Plant
5.1.2 Marine
5.2 By Type
5.2.1 Docosahexanoic acid (DHA)
5.2.2 Eicosapentanoic acid (EPA)
5.2.3 Alpha-Linolenic Acid (ALA)
5.2.4 Others
5.3 By Concentration
5.3.1 High Concentrated
5.3.2 Medium Concentrated
5.3.3 Low Concentrated
5.4 By Application
5.4.1 Food and Beverages
5.4.1.1 Functional Foods & Beverages
5.4.1.2 Infant Formula
5.4.2 Dietary Supplements
5.4.3 Pharmaceuticals
5.4.4 Animal Nutrition
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.1.4 Rest of North America
5.5.2 Europe
5.5.2.1 Spain
5.5.2.2 United Kingdom
5.5.2.3 Germany
5.5.2.4 France
5.5.2.5 Italy
5.5.2.6 Russia
5.5.2.7 Rest of Europe
5.5.3 Asia Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 Rest of Asia-Pacific
5.5.4 South America
5.5.4.1 Brazil
5.5.4.2 Argentina
5.5.4.3 Rest of South America
5.5.5 Middle East and Africa
5.5.5.1 South Africa
5.5.5.2 Saudi Arabia
5.5.5.3 Rest of Middle East and Africa


6 COMPETITIVE LANDSCAPE
6.1 Most Active Companies
6.2 Most Adopted Strategies
6.3 Market Share Analysis
6.4 Company Profiles
6.4.1 Cargill, Incorporated
6.4.2 BASF SE
6.4.3 Corbion NV
6.4.4 Archer Daniels Midland Company
6.4.5 Croda International Plc
6.4.6 Omega Protein Corporation
6.4.7 Biosearch Life
6.4.8 KD Pharma Group
6.4.9 Novotech Nutraceuticals Inc
6.4.10 Clover Corporation Ltd


7 MARKET OPPORTUNITIES AND FUTURE TRENDS